Cite
HARVARD Citation
Wijetunga, A. et al. (2021). Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy. European journal of surgical oncology. 47 (10), pp. 2543-2550. [Online].